Hospital Unviersitario Miguel Servet

Zaragoza 50009

0 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma, Thyroid Eye Disease

Studies at this site

• A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma — Running, not enrolling
• An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2) — Completed